Purgatorio, R.; Gambacorta, N.; de Candia, M.; Catto, M.; Rullo, M.; Pisani, L.; Nicolotti, O.; Altomare, C.D.
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease. Molecules 2021, 26, 5208.
https://doi.org/10.3390/molecules26175208
AMA Style
Purgatorio R, Gambacorta N, de Candia M, Catto M, Rullo M, Pisani L, Nicolotti O, Altomare CD.
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease. Molecules. 2021; 26(17):5208.
https://doi.org/10.3390/molecules26175208
Chicago/Turabian Style
Purgatorio, Rosa, Nicola Gambacorta, Modesto de Candia, Marco Catto, Mariagrazia Rullo, Leonardo Pisani, Orazio Nicolotti, and Cosimo D. Altomare.
2021. "First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease" Molecules 26, no. 17: 5208.
https://doi.org/10.3390/molecules26175208
APA Style
Purgatorio, R., Gambacorta, N., de Candia, M., Catto, M., Rullo, M., Pisani, L., Nicolotti, O., & Altomare, C. D.
(2021). First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease. Molecules, 26(17), 5208.
https://doi.org/10.3390/molecules26175208